Effect of iron and vitamin C co-supplementation in hyperthyroidism patients

Phase 3

Recruiting

• Conditions: Condition 1: Hyperthyroidism. Condition 2: Iron deficiency anemia.; Thyrotoxicosis [hyperthyroidism]; Iron deficiency anemia

• Registration Number: IRCT20090822002365N27
• Lead Sponsor: Iran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 8 March 2022

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

Men and women over 18 years of age with newly diagnosed hyperthyroidism
Body mass index18.5-30 kg / m2
Hemoglobin level less than 12.7 g / dl for women and less than 13 g / dl for men
Start a medication program
No autoimmune diseases and chronic diseases such as diabetes, hypertension, kidney, liver, gallbladder, thyroid, parathyroid, bone, gastrointestinal and hyperphosphatemia disorders
No infectious diseases, malignancies and severe bleeding in the last 2 months
No thalassemia and other blood disorders
Do not use hormonal drugs, anticonvulsants, cholesterol and fat lowering drugs, antacids, blood thinners, and laxatives.
Do not take iron and vitamin C supplements during the last month
No history of other thyroid disorders
In the case of women, the absence of abnormal and irregular menstrual cycles
No pregnancy and lactation
Willingness to cooperate

Exclusion Criteria

Having any acute illness
Changes in medications
Non-regular use of supplements and acceptance rate less than 90%
Migration
Exclusion based on personal preference of participants

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Thyroid stimulating hormone. Timepoint: Before intervention and 8 weeks after intervention. Method of measurement: The level of TSH in serum is with ELISA method.